| Jonathan K Loo, | |
|
3133 W March Ln, Ste 2020, Stockton, CA 95219-2361 | |
| (209) 951-0820 | |
| (209) 951-2348 |
| Full Name | Jonathan K Loo |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 3133 W March Ln, Stockton, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285652776 | NPI | - | NPPES |
| SD0059010 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5901T (California) | Primary |
| Provider Name | Jonathan K. Loo Od, A Professional Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851621312 PECOS PAC ID: 1052452133 Enrollment ID: O20100112000302 |
News Archive
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
Cellectis, a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of Cellectis' advanced product candidate, UCART19.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
Relationships are key to influencing positive health behaviors and should not be forgotten during social distancing due to the COVID-19 pandemic
› Verified 8 days ago
| Provider Name | First Optometric Care Of Northern California Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154972404 PECOS PAC ID: 6002216488 Enrollment ID: O20210608000773 |
News Archive
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
Cellectis, a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of Cellectis' advanced product candidate, UCART19.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
Relationships are key to influencing positive health behaviors and should not be forgotten during social distancing due to the COVID-19 pandemic
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan K Loo, 3133 W March Ln, Ste 2020, Stockton, CA 95219-2361 Ph: (209) 951-0820 | Jonathan K Loo, 3133 W March Ln, Ste 2020, Stockton, CA 95219-2361 Ph: (209) 951-0820 |
News Archive
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
Cellectis, a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of Cellectis' advanced product candidate, UCART19.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
Relationships are key to influencing positive health behaviors and should not be forgotten during social distancing due to the COVID-19 pandemic
› Verified 8 days ago
Dr. William Dale Whitted, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1036 W Robinhood Dr, Suite 105, Stockton, CA 95207 Phone: 209-951-3693 Fax: 209-951-4711 | |
Richard Vanover Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 3133 W March Ln Ste 2020, Stockton, CA 95219 Phone: 209-951-0820 Fax: 209-951-2348 | |
Eyecheck Optometry Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7743 West Ln, Suite A2, Stockton, CA 95210 Phone: 209-636-4914 Fax: 209-208-1819 | |
Timothy Ng, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1101 E March Ln # 0, Stockton, CA 95210 Phone: 209-957-8000 Fax: 209-957-8077 | |
Dr. David Krejchi, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4950 Pacific Ave, Stockton, CA 95207 Phone: 209-477-4114 | |
Vikram Girn, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2571 Blossom Cir, Stockton, CA 95212 Phone: 209-298-6169 | |
Jennifer Pham, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1899 W March Ln, Stockton, CA 95207 Phone: 209-623-4700 |